Zhenqiang He

1.4k total citations
48 papers, 1.0k citations indexed

About

Zhenqiang He is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Zhenqiang He has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Zhenqiang He's work include Glioma Diagnosis and Treatment (14 papers), Lung Cancer Research Studies (7 papers) and Brain Metastases and Treatment (6 papers). Zhenqiang He is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Lung Cancer Research Studies (7 papers) and Brain Metastases and Treatment (6 papers). Zhenqiang He collaborates with scholars based in China, United States and Spain. Zhenqiang He's co-authors include Jian Cai, Yonggao Mou, Hao Duan, Yanqing Gong, Yi Fan, Steven Brem, Lin Zhang, Zhenfeng Zhang, Menggui Huang and Tianrun Liu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Zhenqiang He

45 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenqiang He China 14 302 286 286 260 188 48 1.0k
Kenichi Kawaguchi Japan 23 385 1.3× 215 0.8× 23 0.1× 64 0.2× 78 0.4× 90 1.3k
Zhengxiang Yang China 11 296 1.0× 69 0.2× 41 0.1× 61 0.2× 278 1.5× 13 469
Shaolong Zhou China 15 202 0.7× 95 0.3× 68 0.2× 104 0.4× 92 0.5× 37 566
Zhuo Xi China 18 971 3.2× 84 0.3× 49 0.2× 49 0.2× 891 4.7× 36 1.4k
Jiabo Hu China 17 796 2.6× 264 0.9× 68 0.2× 698 2.7× 395 2.1× 48 1.6k
Shingo Tanaka Japan 18 460 1.5× 136 0.5× 67 0.2× 342 1.3× 222 1.2× 65 1.1k
Changping Wu China 21 745 2.5× 596 2.1× 433 1.5× 85 0.3× 511 2.7× 41 1.6k
Liusheng He China 16 312 1.0× 171 0.6× 115 0.4× 8 0.0× 56 0.3× 48 979

Countries citing papers authored by Zhenqiang He

Since Specialization
Citations

This map shows the geographic impact of Zhenqiang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenqiang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenqiang He more than expected).

Fields of papers citing papers by Zhenqiang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenqiang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenqiang He. The network helps show where Zhenqiang He may publish in the future.

Co-authorship network of co-authors of Zhenqiang He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenqiang He. A scholar is included among the top collaborators of Zhenqiang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenqiang He. Zhenqiang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Hao, Zhenqiang He, Yukun Chen, et al.. (2024). Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. BMC Immunology. 25(1). 83–83.
2.
Yin, Xiujuan, et al.. (2024). Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma. Journal of Nanobiotechnology. 22(1). 243–243. 7 indexed citations
3.
Wang, Zhenning, Zhenqiang He, Yang Hu, et al.. (2023). Oligomer‐Aβ42 suppress glioma progression via potentiating phagocytosis of microglia. CNS Neuroscience & Therapeutics. 30(1). e14495–e14495. 2 indexed citations
4.
Yin, Xiujuan, Huimin Zhao, Zhenqiang He, & Xiao Wang. (2023). Application of aptamer-functionalized nanomaterials in molecular imaging of tumors. Nanotechnology Reviews. 12(1). 3 indexed citations
5.
Wang, Zhenning, Hao Duan, Zhenqiang He, et al.. (2023). Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors. Current Oncology. 30(2). 2227–2236. 1 indexed citations
6.
Zhong, Sheng, Jiaxin Ren, Davy Deng, et al.. (2022). Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics. Journal of neurosurgery. 139(2). 305–314. 17 indexed citations
7.
Wang, Zhenning, Xiaobing Jiang, Jie Lü, et al.. (2022). Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study. Annals of Surgical Oncology. 29(6). 3684–3693. 4 indexed citations
8.
Yang, Fan, Zhenqiang He, Hao Duan, et al.. (2021). Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nature Communications. 12(1). 3424–3424. 114 indexed citations
9.
He, Zhenqiang, Yujie Ma, Zheng Wang, et al.. (2021). Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?. Frontiers in Cell and Developmental Biology. 9. 706286–706286. 56 indexed citations
10.
Yang, Qunying, Chengcheng Guo, Xiaoping Lin, et al.. (2021). Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis. Frontiers in Pharmacology. 12. 804942–804942. 6 indexed citations
11.
Li, De‐Pei, Wanming Hu, Xiaoping Lin, et al.. (2021). CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas. Frontiers in Cell and Developmental Biology. 9. 653240–653240. 2 indexed citations
12.
Zhang, Jie, Qiuyan Xu, Hua Zhang, et al.. (2021). High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas. Translational Oncology. 14(4). 101038–101038. 9 indexed citations
13.
Guo, Xiaoyu, Sheng Zhong, Zhenning Wang, et al.. (2021). Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme. Frontiers in Genetics. 12. 633812–633812. 13 indexed citations
14.
Duan, Hao, Zhenqiang He, Chengcheng Guo, et al.. (2018). Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment. Cancer Management and Research. Volume 10. 2467–2474. 3 indexed citations
15.
Wang, Qirui, Zhenqiang He, Menggui Huang, et al.. (2018). Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nature Communications. 9(1). 559–559. 198 indexed citations
16.
Shao, Meng, Zhenqiang He, Zhixin Yin, et al.. (2018). Xihuang Pill Induces Apoptosis of Human Glioblastoma U‐87 MG Cells via Targeting ROS‐Mediated Akt/mTOR/FOXO1 Pathway. Evidence-based Complementary and Alternative Medicine. 2018(1). 6049498–6049498. 22 indexed citations
17.
He, Zhenqiang, et al.. (2017). Pre-alignment of DTL for China spallation neutron source. Nuclear Techniques. 40(5). 1 indexed citations
18.
He, Zhenqiang, Chao Ke, Hao Duan, et al.. (2017). Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas. Journal of Neuro-Oncology. 132(2). 239–247. 28 indexed citations
19.
He, Zhenqiang, et al.. (2016). Measurement and Research of Control Network’s Accuracy of CSNS Linear Accelerator. Bulletin of Surveying and Mapping. 104–107. 1 indexed citations
20.
Cai, Jian & Zhenqiang He. (2006). CONSTITUTIVE RELATIONSHIP OF SQUARE CFT WITH BINDING BARS. Engineering Mechanics. 23(10). 145–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Kawaguchi Breakdown of academic impact, for papers by Zhengxiang Yang Breakdown of academic impact, for papers by Shaolong Zhou Breakdown of academic impact, for papers by Zhuo Xi Breakdown of academic impact, for papers by Jiabo Hu Breakdown of academic impact, for papers by Shingo Tanaka Breakdown of academic impact, for papers by Changping Wu Breakdown of academic impact, for papers by Liusheng He
Rankless by CCL
2026